|

Prospective Assessment of Cost-effectiveness and Side-effects of Depressive Patients Treated With ECT or TCA

RECRUITINGSponsored by Radboud University Medical Center
Actively Recruiting
SponsorRadboud University Medical Center
Started2022-01-01
Est. completion2024-12-31
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT05306184

Summary

Prospective observational cohort study to determine cost-effectiveness of ECT compared to medication in the treatment of major depressive disorder (MDD) in the Netherlands.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* adult patients (\>18 years) with a major depressive disorder who will either start with ECT or medication
* failed response to at least 1 adequate dose-duration trial with antidepressants
* moderate or severe depression (HDRS-17 \>16)

Exclusion Criteria:

* lifetime diagnosis schizophrenia or schizoaffective disorder, current substance abuse disorder, organic brain syndrome
* the presence of a concurrent significant medical condition impeding the ability to participate

Conditions2

DepressionDepressive Disorder, Major

Browse More Trials

Depression trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.